Spin-off news

Evotec and Related Sciences expand integrated drug discovery and development partnership

MorphoSys expects top-line results from the Phase 3 study of pelabresib in myelofibrosis in early 2024

US-Patent for production of alpha-Ionon from Phytowelt

Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes

Lipotype, a Leading Lipidomics Service Provider, launches US subsidiary in Cambridge, Massachusetts